Extrapolating Survival Data Using Historical Trial–Based a Priori Distributions von Soikkeli, Fanni, MSc, Hashim, Mahmoud, MPH, Ouwens, Mario, PhD, Postma, Maarten, PhD, Heeg, Bart, PhD

Volltext

Improved estimation of overall survival and progression-free survival for state transition modeling von Wigfield, Peter C, Heeg, Bart, Ouwens, Mario

Volltext

Proteasome inhibitors and IMiDs can overcome some high-risk cytogenetics in multiple myeloma but not gain 1q21 von Nahi, Hareth, Våtsveen, Thea Kristin, Lund, Johan, Heeg, Bart M.S., Preiss, Birgitte, Alici, Evren, Møller, Michael Boe, Wader, Karin Fahl, Møller, Hanne E.H., Grøseth, Lill Anny, Østergaard, Brian, Dai, Hong Yan, Holmberg, Erik, Gahrton, Gösta, Waage, Anders, Abildgaard, Niels

Volltext

Modelling Approaches: The Case of Schizophrenia von Heeg, Bart M. S., Damen, Joep, Buskens, Erik, Caleo, Sue, de Charro, Frank, van Hout, Ben A.

Volltext

Bayesian hierarchical model-based network meta-analysis to overcome survival extrapolation challenges caused by data immaturity von Heeg, Bart, Verhoek, Andre, Tremblay, Gabriel, Harari, Ofir, Soltanifar, Mohsen, Chu, Haitao, Roychoudhury, Satrajit, Cappelleri, Joseph C

Volltext

Which Factors Enhance Positive Drug Reimbursement Recommendation in Scotland? A Retrospective Analysis 2006–2013 von Charokopou, Mata, PharmD, MSc, Majer, Istvan M., PhD, Raad, Johan de, PharmD, MSc, Broekhuizen, Stefan, BSc, Postma, Maarten, PhD, Heeg, Bart, MSc

Volltext

Assessing Uncertainties Surrounding Combined Endpoints for Use in Economic Models von Heeg, Bart M., van Hout, Ben A.

Volltext

Long-term clopidogrel therapy in patients receiving percutaneous coronary intervention von HEEG, Bart M. S, PETERS, Ron J. G, BOTTEMAN, Marc, VAN HOUT, Ben A

Volltext

Costs and consequences of clopidogrel versus aspirin for secondary prevention of ischaemic events in (high-risk) atherosclerotic patients in Sweden: A lifetime model based on the C... von Logman, J. Floris S., Heeg, Bart M. S., Herlitz, Johan, van Hout, Ben A.

Volltext

Comparative efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) without and with daratumumab (D‐VTd) in CASSIOPEIA versus VTd in PETHEMA/GEM in transplant‐eligi... von Moreau, Philippe, Hulin, Cyrille, Zweegman, Sonja, Hashim, Mahmoud, Hu, Yannan, Heeg, Bart, Boer, Carla, Vanquickelberghe, Veronique, Kampfenkel, Tobias, He, Jianming, Lam, Annette, Cote, Sarah, Sonneveld, Pieter

Volltext

The Inflation Reduction Act: An Opportunity to Accelerate Confidence in Real-World Evidence in the United States von Arora, Paul, Gupta, Alind, Mackay, Emma, Heeg, Bart, Thorlund, Kristian

Volltext

The Cost-Effectiveness of Atypicals in the UK von Heeg, Bart, MSc, Buskens, Erik, MD, Botteman, Marc, MSc, Caleo, Sue, MSc, Ingham, Mike, MSc, Damen, Joep, MSc, de Charro, Frank, PhD, van Hout, Ben, PhD

Volltext

A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss von Treur, Maarten, Heeg, Bart, Möller, Hans-Jürgen, Schmeding, Annette, van Hout, Ben

Volltext

A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma von Munshi, Nikhil C., Avet-Loiseau, Herve, Anderson, Kenneth C., Neri, Paola, Paiva, Bruno, Samur, Mehmet, Dimopoulos, Meletios, Kulakova, Margarita, Lam, Annette, Hashim, Mahmoud, He, Jianming, Heeg, Bart, Ukropec, Jon, Vermeulen, Jessica, Cote, Sarah, Bahlis, Nizar

Volltext

PP113 Reimbursement Of Oncology Therapies With Limited Clinical Evidence In The Netherlands von Smalbrugge, David, van Beekhuizen, Sophie, Heeg, Bart

Volltext

Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in Germany von Laux, Gerd, Heeg, Bart, van Hout, Ben A, Mehnert, Angelika

Volltext

Alone, together: On the benefits of Bayesian borrowing in a meta‐analytic setting von Harari, Ofir, Soltanifar, Mohsen, Verhoek, Andre, Heeg, Bart

Volltext

Can duration of response be used as a surrogate endpoint for overall survival in advanced non-small cell lung cancer? von Pfeiffer, Boris M, Kulakova, Margarita, Hashim, Mahmoud, Heeg, Bart

Volltext

Modelling the impact of compliance on the costs and effects of long-acting risperidone in Canada von Chue, P S, Heeg, Bart, Buskens, Erik, van Hout, Ben A

Volltext

MET Exon 14 Skipping in NSCLC: A Systematic Literature Review of Epidemiology, Clinical Characteristics, and Outcomes von Mazieres, Julien, Vioix, Helene, Pfeiffer, Boris M., Campden, Rhiannon I., Chen, Zhiyuan, Heeg, Bart, Cortot, Alexis B.

Volltext